Samjin Pharm (005500) — Strategic Asset Allocation Index
Samjin Pharm (005500) has a Strategic Asset Allocation Index of 36.7% as of September 2018. Strategic assets (PP&E of ₩73.77 Billion plus long-term investments of ₩5.95 Billion) total ₩79.72 Billion, measured against net assets of ₩217.52 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Samjin Pharm balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Samjin Pharm Strategic Asset Allocation Index (2013–2017)
This chart shows how Samjin Pharm's Strategic Asset Allocation Index has evolved across 5 annual periods from 2013 to 2017. As of September 2018, the index stands at 36.7%, representing strategic assets of ₩79.72 Billion against net assets of ₩217.52 Billion KRW. For live market cap and overall valuation, see 005500 company net worth.
Annual Strategic Asset Allocation Index for Samjin Pharm (2013–2017)
The table below presents the year-by-year Strategic Asset Allocation Index for Samjin Pharm from 2013 to 2017, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Samjin Pharm book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2017 | 41.1% | ₩79.54 Billion | ₩74.87 Billion | ₩4.67 Billion | ₩193.47 Billion | ▼ -4.3 pp |
| 2016 | 45.4% | ₩77.01 Billion | ₩72.40 Billion | ₩4.62 Billion | ₩169.69 Billion | ▼ -7.9 pp |
| 2015 | 53.3% | ₩78.89 Billion | ₩71.15 Billion | ₩7.74 Billion | ₩148.06 Billion | ▼ -8.0 pp |
| 2014 | 61.3% | ₩77.21 Billion | ₩70.02 Billion | ₩7.20 Billion | ₩126.04 Billion | ▼ -0.3 pp |
| 2013 | 61.6% | ₩69.59 Billion | ₩62.88 Billion | ₩6.71 Billion | ₩112.98 Billion | — |